Dr. Robert Booth
Chief Scientific Officer
Robert Booth, Ph.D., joined Celera Genomics as Chief Scientific Officer in August 2002. In this new position, Dr. Booth is responsible for integrating and leading all of Celera’s therapeutic discovery and development activities. He oversees an R&D staff of approximately 300 people, including scientists supporting the proteomics, informatics and bioinformatics projects ongoing in Rockville, MD, as well as the small molecule therapeutics programs in South San Francisco, CA.
Dr. Booth has over 20 years of experience in the pharmaceutical industry, including 13 with Hoffmann-La Roche. In his last position before joining Celera, Dr. Booth was Senior Vice President responsible for the Inflammatory and Viral Diseases Business Unit, as well as Central R&D at Roche Bioscience. In this role, he was responsible for creating strategies and directing research activities to generate new therapeutics. Dr. Booth was a member of the Global Research Management Team and Head of the Global Biology Team. In addition, he orchestrated a number of key external therapeutic collaborations.
Previously, Dr. Booth spent three years managing research activities at Wellcome Research Laboratories, and four years at Searle Research & Development.
Dr. Booth earned a Ph.D. in Biochemistry from the St Bartholomew's Hospital Medical School at the University of London. He earned a BSc in Biochemistry from London University’s University College.
